Send feedback

ABCA4 p.Asp1918Val

c.5753A>T · rs1659470705 · VCV871507

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.8405 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000169%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
ABCA4-related retinopathy

ClinGen expert panel — ABCA4 VCEP

Pathogenic for ABCA4-related retinopathy. Applied ACMG criteria (verbatim):

PP3_Moderate PM2_Supporting PS4 PP4_Supporting PM3

Curation rationale (ClinGen, verbatim)

The c.5732A>T (NM_000350.3) variant in ABCA4 is a missense variant predicted to cause substitution of aspartic acid by valine at amino acid 1918 (p.Asp1918Val). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.836 which is above the threshold of >0.772, evidence that predicts a damaging effect on ABCA4 function (PP3_Moderate). The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls. The OR is infinity and the CI is 2.24 to infinity, which is above the ABCA4 VCEP threshold of ≥5, where the CI does not contain 1 (PS4; PMID: 35120629). At least one patient met ABCA4-related retinopathy phenotype criteria (PP4, PMID: 27939946). This variant has been detected in at least four individuals with ABCA4-related retinopathy (PMID: 27939946, 32531858, 38003421). Of those individuals, two were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and one of those were confirmed in trans by parental testing (PMID: 27939946, 32531858; PM3). In summary, this variant meets the criteria to be classified as pathogenic for ABCA4-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen ABCA4 VCEP (Specification Version v.1.0): PS4, PM3, PP3, PP4_Supporting, PM2_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.8405likely pathogenic ✓ concordant with ClinVar
REVEL0.836moderately pathogenic-leaning
SaProtLLR -13.46damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 1.9, phastCons 1
Regional constrainto/e 0.98unconstrained · MANE · 128 kb · p 0.24 · regional, not allelic
Overall
CADD24.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000169% European (non-Finnish) · 2/1,179,950 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000137% 2/1,461,792 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ABCA4
Protein
p.Asp1918Val
Coding
c.5753A>T
MANE Select
NM_000350
dbSNP
rs1659470705
Type
single nucleotide variant
Location
chr1:94008833 (GRCh38)
Gene constraint
LOEUF 0.786 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 75.96 · 8 PDB
Residue 1918
a UniProt-annotated variant site (in cord3; uncertain significance); a UniProt-annotated variant site (in stgd1; uncertain significance); a UniProt-annotated variant site (found in a patient with chorioretinal atrophy; uncertain significance); a UniProt-annotated variant site (found in a patient with macular dystrophy; uncertain significance); a UniProt-annotated variant site (in stgd1 and cord3; uncertain significance); a UniProt-annotated variant site (sequence variant); a UniProt-annotated variant site (in stgd1 and ffm; uncertain significance)
Full ABCA4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abca4-p-asp1918val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown